{"id":"NCT02246127","sponsor":"Grupo Espanol de Tumores Neuroendocrinos","briefTitle":"Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor","officialTitle":"Randomized Open Label Study to Compare the Efficacy and Safety of Everolimus Followed by Chemotherapy With Streptozotocin- Fluorouracilo (STZ-5FU) Upon Progression or the Reverse Sequence, in Advanced Progressive Pancreatic NETs (pNETs)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-27","primaryCompletion":"2020-11-18","completion":"2021-07-12","firstPosted":"2014-09-22","resultsPosted":"2025-05-11","lastUpdate":"2025-05-11"},"enrollment":141,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Neuroendocrine Tumors"],"interventions":[{"type":"DRUG","name":"Drug: Everolimus","otherNames":["Afinitor"]},{"type":"DRUG","name":"STZ-5FU","otherNames":["STZ based Chemotherapy"]}],"arms":[{"label":"Sequence A, drug: everolimus first","type":"ACTIVE_COMPARATOR"},{"label":"Sequence B, drug: STZ - 5FU first","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to compare streptozotocin (STZ) vs everolimus as first line treatment for advanced pNET and to elucidate which sequence of STZ based chemotherapy and the mammalian Target of Rapamycin (mTOR) inhibitor, everolimus, gives better results in terms of second Progression Free Survival (PFS) in well differentiated and advanced pancreatic NETs.","primaryOutcome":{"measure":"First Progression Free Survival (PFS1)","timeFrame":"At 12 months","effectByArm":[{"arm":"Sequence A, Drug: Everolimus First","deltaMin":71.4,"sd":null},{"arm":"Sequence B, Drug: STZ - 5FU First","deltaMin":61.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.229"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":13},"locations":{"siteCount":37,"countries":["Denmark","France","Germany","Italy","Netherlands","Spain","Sweden","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":28,"n":105},"commonTop":["Fatigue","Mucositis oral","Nausea","Diarrhea","Hyperglycemia"]}}